Xunlu AI is an innovative startup that focuses on the development of AI-powered customer service technologies. Xunlu AI provides AI intelligent customer service and sales robots to businesses in a variety of industries via highly tailored AI solutions, assisting businesses in achieving their goals of cost reduction and increased productivity.
Rubedo Life Sciences, Inc. is a biopharmaceutical company based in Sunnyvale, California, focused on developing therapies that target senescent cells responsible for various age-related diseases. Established in 2018, the company utilizes its proprietary ALEMBIC drug discovery platform to create a pipeline of innovative therapeutic candidates. These candidates include novel small molecules designed to selectively address senescent cells, which contribute to the progression of several chronic conditions, including pulmonary, dermatological, oncological, neurodegenerative, and fibrotic diseases. Rubedo's leadership team comprises experienced professionals from the fields of chemistry, technology, and life sciences, bringing a wealth of knowledge in drug development and commercialization.
Mojo Vision Inc. is a company based in Saratoga, California, established in 2015, that specializes in augmented reality technology. The firm is focused on developing high-performance micro-LED displays for various applications, including consumer, enterprise, and government sectors. It has created the world's smallest and densest dynamic display integrated into a smart contact lens, designed to provide users with timely information without disrupting their focus. This innovative product allows for hands-free connectivity and access to relevant information, thereby minimizing reliance on traditional mobile devices. Additionally, Mojo Vision has formed a joint development agreement with Menicon Co., Ltd. to explore smart contact lens products further, leveraging its advanced micro-LED technology and manufacturing processes to disrupt the display industry.
DigiFT Tech intends to offer regulated decentralized finance solutions on the Ethereum public blockchain. operate the first regulatory-compliant digital asset exchange, where asset owners can issue blockchain-based security tokens and investors can trade with continuous liquidity through an Automatic Market Maker mechanism.
Jimeng Intelligent is a technology-driven industrial Internet platform company for the manufacturing industry. It also offers a digital factory platform that features massive data storage, statistical analysis framework, alarm detection framework, machine learning framework, and big data visualization enabling equipment monitoring, and staff efficiency.
Synchron develops an implantable medical device known as a stentrode, which is designed to establish a brain-computer interface. This minimally invasive device is delivered to the brain via a catheter and features electrode arrays that interpret neuronal signals. By modulating neural activity in targeted areas, the stentrode enables patients with motor impairments to regain control over digital devices, prosthetics, and other assistive technologies using their thoughts. Synchron's innovative approach aims to enhance the quality of life for individuals with significant mobility challenges.
WhizAI is the first and only AI-powered analytics platform purpose-built for life sciences and healthcare. It puts insights directly into the hands of business users empowering decision-makers to drive more informed and faster business decisions at lower cost. With its deep understanding of the life sciences and healthcare domains and user intent, the platform delivers insights without the delays of traditional BI dashboards. Fast, easy, and scalable, WhizAI is transforming analytics with artificial intelligence optimized for life sciences and healthcare making WhizAI the trusted partner of choice at top global companies. Simply ask a question about sales, market access, patient services, or clinical trials -- and WhizAI answers it instantly. WhizAI's conversational interface allows users to simply talk to the enterprise data giving them complete autonomy to drill into every level of detail along with real-time updates. WhizAI’s advanced machine learning algorithms scan entire data sets to deliver proactive alerts and automatically surface anomalies, easily pinpointing stagnating sales, market share changes, patient drop-offs and much more. WhizAI enjoys nearly 100% adoption by business users, contributes to a 60% reduction in calls to IT and a 50% reduction in operational overhead within the first few months of implementation.
Socialtrait is a company that specializes in developing AI-powered solutions aimed at predicting, measuring, and enhancing the effectiveness of brand concepts. Its platform provides a range of tools that facilitate reputation risk management, audience insights, competitive analysis, and rapid A/B testing. By leveraging these tools, brands can make informed decisions regarding their content strategies, ultimately driving greater engagement and success.
Turn.bio is a biotechnology company focused on developing drugs aimed at reversing aging and age-related diseases. Leveraging its patented mRNA platform technology, known as ERA, the company addresses the effects of aging on the epigenome, thereby restoring optimal gene expression. Turn.bio’s innovative approach enables the body to heal itself by instructing specific cells to combat diseases or repair damaged tissues. The company targets a range of medical indications, including immune-related diseases such as cancer, dermatological conditions, ophthalmology, osteoarthritis, and issues related to the muscular system. Through its advanced delivery platform, eTurna, Turn.bio seeks to enhance the effectiveness of nucleic acid therapeutics in promoting health and longevity.
WhizAI is the first and only AI-powered analytics platform purpose-built for life sciences and healthcare. It puts insights directly into the hands of business users empowering decision-makers to drive more informed and faster business decisions at lower cost. With its deep understanding of the life sciences and healthcare domains and user intent, the platform delivers insights without the delays of traditional BI dashboards. Fast, easy, and scalable, WhizAI is transforming analytics with artificial intelligence optimized for life sciences and healthcare making WhizAI the trusted partner of choice at top global companies. Simply ask a question about sales, market access, patient services, or clinical trials -- and WhizAI answers it instantly. WhizAI's conversational interface allows users to simply talk to the enterprise data giving them complete autonomy to drill into every level of detail along with real-time updates. WhizAI’s advanced machine learning algorithms scan entire data sets to deliver proactive alerts and automatically surface anomalies, easily pinpointing stagnating sales, market share changes, patient drop-offs and much more. WhizAI enjoys nearly 100% adoption by business users, contributes to a 60% reduction in calls to IT and a 50% reduction in operational overhead within the first few months of implementation.
Pear Therapeutics, Inc. is a healthcare company specializing in the discovery, development, and delivery of software-based therapeutics aimed at treating behavioral health disorders, including addiction, schizophrenia, anxiety, depression, and chronic insomnia. Founded in 2013 and headquartered in Boston, with an additional office in San Francisco, Pear Therapeutics offers a range of digital therapies designed to enhance treatment outcomes. Notable products include reSET, a tool for substance abuse treatment used alongside traditional therapy; reSET-O, which addresses opioid use disorder; and Somryst, aimed at chronic insomnia. The company also provides PearConnect, a patient services center that connects users with advocates, clinicians, and insurance providers to facilitate support and resource access throughout treatment. By integrating digital interventions with pharmaceuticals, Pear Therapeutics aims to improve patient engagement, clinical outcomes, and cost-effectiveness in healthcare.
Ombre is a provider of microbiome testing kits that focus on personalized health solutions. The company offers subscription-based services that include customized microbiome testing and probiotics tailored to individual needs. Through its testing kits, Ombre delivers actionable insights aimed at preventing chronic diseases such as obesity, cystic fibrosis, and Alzheimer's. By addressing the root causes of gut-related issues, Ombre empowers customers to improve their overall health and well-being with science-backed interventions.
Synchron develops an implantable medical device known as a stentrode, which is designed to establish a brain-computer interface. This minimally invasive device is delivered to the brain via a catheter and features electrode arrays that interpret neuronal signals. By modulating neural activity in targeted areas, the stentrode enables patients with motor impairments to regain control over digital devices, prosthetics, and other assistive technologies using their thoughts. Synchron's innovative approach aims to enhance the quality of life for individuals with significant mobility challenges.
Turn.bio is a biotechnology company focused on developing drugs aimed at reversing aging and age-related diseases. Leveraging its patented mRNA platform technology, known as ERA, the company addresses the effects of aging on the epigenome, thereby restoring optimal gene expression. Turn.bio’s innovative approach enables the body to heal itself by instructing specific cells to combat diseases or repair damaged tissues. The company targets a range of medical indications, including immune-related diseases such as cancer, dermatological conditions, ophthalmology, osteoarthritis, and issues related to the muscular system. Through its advanced delivery platform, eTurna, Turn.bio seeks to enhance the effectiveness of nucleic acid therapeutics in promoting health and longevity.
Rubedo Life Sciences, Inc. is a biopharmaceutical company based in Sunnyvale, California, focused on developing therapies that target senescent cells responsible for various age-related diseases. Established in 2018, the company utilizes its proprietary ALEMBIC drug discovery platform to create a pipeline of innovative therapeutic candidates. These candidates include novel small molecules designed to selectively address senescent cells, which contribute to the progression of several chronic conditions, including pulmonary, dermatological, oncological, neurodegenerative, and fibrotic diseases. Rubedo's leadership team comprises experienced professionals from the fields of chemistry, technology, and life sciences, bringing a wealth of knowledge in drug development and commercialization.
PhaseShift Technologies is addressing the critical need for new materials that can overcome limitations in performance, efficiency, cost, availability, and sustainability. Traditional material development relies heavily on trial-and-error, requiring costly and time-consuming physical experiments. This approach can extend projects over 10-20 years and cost millions of dollars, with no guarantee of success. PhaseShift's Rapid Alloy Design (RAD)™ technology revolutionizes this process by using AI to create optimized alloys tailored to specific use cases. Paired with Multi-Scale Simulations to accurately predict material performance, RAD™ minimizes the time and effort spent on unsuccessful trials. This leads to faster, more efficient development cycles and a significant reduction in resources required to meet design goals. Through the RAD™ platform, PhaseShift designs a portfolio of innovative alloys, which are commercialized via strategic partnerships with manufacturers.
Iota Biosciences, Inc. is a medical device company based in Berkeley, California, founded in 2017. It specializes in the development of wireless sensors and devices aimed at monitoring, measuring, and stimulating internal nerves, muscles, and organs for electroceutical applications, particularly in the treatment of immune and neural disorders. The company has pioneered neural dust technology, utilizing implantable, mote-sized ultrasonic sensors that enable untethered and real-time wireless cortical recordings, improving the methods by which physicians monitor and treat various diseases. Iota's mission is to create safe and effective bioelectronic devices that transform disease management and enhance patient care. As a subsidiary of Astellas Pharma, Iota is committed to leveraging innovative science and technology to advance the field of bioelectronics and make a meaningful impact on patients' lives.
Mojo Vision Inc. is a company based in Saratoga, California, established in 2015, that specializes in augmented reality technology. The firm is focused on developing high-performance micro-LED displays for various applications, including consumer, enterprise, and government sectors. It has created the world's smallest and densest dynamic display integrated into a smart contact lens, designed to provide users with timely information without disrupting their focus. This innovative product allows for hands-free connectivity and access to relevant information, thereby minimizing reliance on traditional mobile devices. Additionally, Mojo Vision has formed a joint development agreement with Menicon Co., Ltd. to explore smart contact lens products further, leveraging its advanced micro-LED technology and manufacturing processes to disrupt the display industry.
Krisp develops an AI-powered application that enhances audio quality for remote workers by eliminating background noise and improving voice clarity during calls. The app integrates seamlessly with various conferencing and recording platforms and is compatible with all types of headsets and microphones, including built-in, Bluetooth, and USB devices. Krisp's technology not only cancels unwanted noise but also recovers lost sound packets during network transfers, transforming low-bitrate audio into high-definition quality. This makes it particularly useful for contact centers, telecommunications, and critical communication scenarios, ensuring clear and professional audio in a variety of settings.
Ombre is a provider of microbiome testing kits that focus on personalized health solutions. The company offers subscription-based services that include customized microbiome testing and probiotics tailored to individual needs. Through its testing kits, Ombre delivers actionable insights aimed at preventing chronic diseases such as obesity, cystic fibrosis, and Alzheimer's. By addressing the root causes of gut-related issues, Ombre empowers customers to improve their overall health and well-being with science-backed interventions.
Teambrella is a social app that is destined to replace insurance. Teambrella is what insurance has always strived to be: a tool for sharing risks with peers and helping those in need. But this time, we don’t just declare the absence of conflicts of interest — we align interests of all parties and make the whole process provably fair.
Nextbiotics is a biotechnology company founded in 2017 and headquartered in Mountain View, California. The company specializes in engineering viruses, specifically bacteriophages, to combat antibiotic-resistant bacteria. Utilizing a platform that combines bacteriophage therapy with CRISPR technology, Nextbiotics develops innovative treatments aimed at reversing antibiotic resistance and addressing various global health challenges. By precisely modulating the microbiome, the company enables medical professionals to effectively treat and prevent infections caused by drug-resistant pathogens.
Shanghai Shihou Network Technology Co., Ltd. is a private company based in Shanghai, China, that operates a mobile gaming and live broadcasting platform. The platform caters to the entertainment sector by providing a diverse selection of online and real-time games, aimed at enhancing user engagement and entertainment experiences. Through its services, Shihou TV connects gamers and viewers, facilitating a dynamic environment for gaming and entertainment.
Teambrella is a social app that is destined to replace insurance. Teambrella is what insurance has always strived to be: a tool for sharing risks with peers and helping those in need. But this time, we don’t just declare the absence of conflicts of interest — we align interests of all parties and make the whole process provably fair.
HOTEL NIDA is a branded budget hotel internet marketplace. The company's website provides information about trip destinations, hotel pricing, and lodging availability. It allows consumers to look for, compare, and book services after entering pertinent information.
Survios is a virtual reality company that creates groundbreaking interactive content powered by cutting edge immersive technology. It is composed of a team of dreamers, makers, artists, thinkers, and gamers. It's focus is all about engaging games., immersive tech and unparalleled presence. Nathan Burba, James Iliff and Alexander Silkin launched Project Holodeck as an interdisciplinary effort at the University of Southern California’s Games program. From Project Holodeck they founded Survios, and continue to focus on virtual reality gaming and immersive technology.
Lumus (www.lumus-optical.com) products enable the fusion of the digital and physical world, allowing businesses and individuals to maximize the potential of augmented reality and smart eyewear today. Lumus has developed leading technology for see-through wearable displays, via its patented Light-guide Optical Element (LOE) platform to market leading producers of smart glasses and augmented reality eyewear. Lumus' technology enables a small natural looking form factor, wide field of view and true see-through performance.
Founded in January 2015 by Ryan Holmes, CEO, SpaceVR is the world’s first virtual reality platform allowing users to #BeAnAstronaut and experience space firsthand 2000 floatation tanks across the globe with it’s patented pending waterproof, float tank compatible VR headset for super learning, deep therapy, and deep entertainment. Headlining with two unprecedented content pieces: Orbit Therapy and Language Learning. The former allowing everyone to experience orbiting the Earth from SpaceVR’s LIVE satellite, reducing clinical depression and diagnosed anxiety as a therapy protocol. The latter will allow anyone to super learn a language in an unprecedented 30 days. This is the beginning of hyper-accelerated learning humanity.
ElMindA vision is to bring a paradigm change to the management of brain disorders and injuries, by transforming state of the art neuroscience into bed-side clinical practice. ElMindA has developed the BNA™ technology platform, which for the first time allows high resolution visualization and evaluation of the complex neuro-physiological interconnections of the human brain at work, capturing information on the composition, connectivity, synchronization and operation of brain networks.
Sólfar Studios is a virtual reality gaming studio founded by three industry veterans with over 20 years of experience in online worlds, games, and virtual reality. The studio focuses on creating and publishing games across all major VR platforms, including PlayStation's Project Morpheus, Steam VR, and Oculus Rift. Sólfar is dedicated to delivering transformative experiences that evoke visceral emotions, fostering an immersive environment for users. The company maintains a selective approach to talent and collaborators, ensuring a commitment to quality and impactful productions while remaining agile in the ever-evolving gaming landscape.
Yunniao Delivery, established in November 2014, specializes in regional and city distribution services, focusing on B2B and O2O supply chain solutions. The company connects Chinese enterprises requiring same-city courier services with individuals who offer transportation using vans. This platform is designed to provide personalized services to a diverse clientele, including chain stores, distributors, brands, and manufacturers. Yunniao Delivery enhances customer experience through on-site monitoring, management, and the provision of insured goods along with cash-on-delivery options, ensuring a reliable and efficient distribution network.